Patent · US Active

Oral products with reduced irritation

US11672862B2 · kind B2 · utility

0Cited by
90References
18Claims
0Family size

Assignee

Inventors

Key dates

Filing dateDec 9, 2019
Grant dateJun 13, 2023
Priority date
Expiry dateSep 12, 2040

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61K47/38
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The disclosure provides products configured for oral use, the products including one or more agents adapted to or configured to reduce irritation that may be associated with release of a component from the products. Xylitol in particular may be useful as an irritation reducing agent. The disclosure further provides methods of reducing irritation associated with the release of one or more components from an oral composition or product.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.